Short communication: the cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004

Vista sencilla de ítem
dc.contributor.authorVega, Juan Carlos
dc.contributor.authorSánchez Polania, Boris Fernando
dc.contributor.authorMontero, Luz Mery
dc.contributor.authorRozo Montaña, Rafael Augusto
dc.contributor.authordel Pilar Mahecha, Mercedes
dc.contributor.authorDueñes, Bladimir
dc.contributor.authorBaron, Ángela Rocío
dc.contributor.authorReithinger, Richard
dc.contributor.orcidSánchez Polania, Boris Fernando [0000-0002-6096-136X]
dc.contributor.orcidSánchez Polania, Boris Fernando [0000-0002-6096-136X]
dc.date.accessioned2020-08-14T19:17:07Z
dc.date.available2020-08-14T19:17:07Z
dc.date.issued2012
dc.description.abstractenglishWe calculated ranges for the cost per disability adjusted life year (DALY) averted for cutaneous leishmaniasis (CL) treatment during an ongoing epidemic of CL in Chaparral, Colombia. Using operational clinical and cost data, we calculated that the cost of treating leishmaniasis patients with standard pentavalent antimony was US$345 (95% CI 277–488) per patient treated and cured. The cost per DALY averted per patient cured with antimony was estimated to be approximately US$15 000 (95% CI 12 226–21 532).eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1111/j.1365-3156.2007.01962.x
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1365-3156
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlhttps://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/3801
dc.language.isoeng
dc.publisherWiley-Blackwellspa
dc.publisher.journalTropical medicine and international healthspa
dc.relation.ispartofseriesTropical medicine and international health, 1365-3156, Vol. 12, Nro. 12, 2012, p. 1540-1544spa
dc.relation.urihttps://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-3156.2007.01962.x
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2007-12-07
dc.rights.localAcceso abiertospa
dc.subject.keywordsCost-effectiveness analysisspa
dc.subject.keywordsLeishmaniasisspa
dc.subject.keywordsPrevention and controlspa
dc.subject.keywordsTreatmentspa
dc.titleShort communication: the cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004spa
dc.title.translatedShort communication: the cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004spa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Juan Carlos Vega Boris Fernando Sanchez_2007.pdf
Tamaño:
72.1 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos